Literature DB >> 22977716

Nasal hemangiopericytoma causing oncogenic osteomalacia.

Sung Il Cho1, Nam Yong Do, Seung Woo Yu, Ji Yun Choi.   

Abstract

Oncogenic osteomalacia is a rare cause that makes abnormalities of bone metabolism. Our case arose in a 47-year-old woman presenting a nasal mass associated with osteomalacia. We excised the mass carefully. After surgery, it was diagnosed as hemangiopericytoma and her symptoms related with osteomalacia were relieved and biochemical abnormalities were restored to normal range. We report and review a rare case of nasal hemangiopericytoma that caused osteomalacia.

Entities:  

Keywords:  Nasal hemangiopericytoma; Osteomalacia

Year:  2011        PMID： 22977716      PMCID： PMC3437420          DOI： 10.3342/ceo.2012.5.3.173

Source DB:  PubMed          Journal:  Clin Exp Otorhinolaryngol        ISSN： 1976-8710            Impact factor:   3.372


  12 in total

1.  Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma.

Authors:  Carlos Fuentealba; Delia Pinto; Francisco Ballesteros; Daniel Pacheco; Oscar Boettiger; Néstor Soto; Wanda Fernandez; Fernando Gabler; Gilberto Gonzales; Antonio J Reginato
Journal:  J Clin Rheumatol       Date:  2003-12       Impact factor: 3.517

2.  Sinonasal hemangiopericytomas: a clinicopathologic and immunohistochemical study of seven cases.

Authors:  P J Catalano; M Brandwein; D K Shah; M L Urken; W Lawson; H F Biller
Journal:  Head Neck       Date:  1996 Jan-Feb       Impact factor: 3.147

Review 3.  Oncogenic osteomalacia: is there a new phosphate regulating hormone?

Authors:  A E Nelson; B G Robinson; R S Mason
Journal:  Clin Endocrinol (Oxf)       Date:  1997-12       Impact factor: 3.478

4.  A paranasal tumor associated with tumor-induced osteomalacia.

Authors:  Go Inokuchi; Hitoshi Tanimoto; Haruhiko Ishida; Toshitsugu Sugimoto; Mika Yamauchi; Akimitsu Miyauchi; Ken-Ichi Nibu
Journal:  Laryngoscope       Date:  2006-10       Impact factor: 3.325

5.  Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Authors:  Kenneth B Jonsson; Richard Zahradnik; Tobias Larsson; Kenneth E White; Toshitsugu Sugimoto; Yasuo Imanishi; Takehisa Yamamoto; Geeta Hampson; Hiroyuki Koshiyama; Osten Ljunggren; Koichi Oba; In Myung Yang; Akimitsu Miyauchi; Michael J Econs; Jeffrey Lavigne; Harald Jüppner
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Osteomalacia cured by surgery.

Authors:  A Furco; M Roger; B Mouchet; O Richard; X Martinache; A Fur
Journal:  Eur J Intern Med       Date:  2002-02       Impact factor: 4.487

Review 7.  A haemangiopericytoma of the ethmoid sinus causing oncogenic osteomalacia: a case report and review of the literature.

Authors:  T J Beech; A Rokade; N Gittoes; A P Johnson
Journal:  Int J Oral Maxillofac Surg       Date:  2007-05-10       Impact factor: 2.789

Review 8.  Oncogenic osteomalacia: case report and review of head and neck associated tumours.

Authors:  X Gonzalez-Compta; M Mañós-Pujol; M Foglia-Fernandez; E Peral; E Condom; T Claveguera; M Dicenta-Sousa
Journal:  J Laryngol Otol       Date:  1998-04       Impact factor: 1.469

9.  Occult nasal sinus tumours causing oncogenic osteomalacia.

Authors:  Helen Kenealy; Ian Holdaway; Andrew Grey
Journal:  Eur J Intern Med       Date:  2008-03-10       Impact factor: 4.487

10.  Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.

Authors:  G E Wilkins; S Granleese; R G Hegele; J Holden; D W Anderson; G P Bondy
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958
View more
  6 in total

1.  A case of oncogenic osteomalacia due to occult nasal sinus tumor.

Authors:  Sayantan Ray; Partha Pratim Chakraborty; Kaushik Biswas; Sujoy Ghosh; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  Clin Cases Miner Bone Metab       Date:  2015 Jan-Apr

2.  Phosphaturic Mesenchymal Tumor.

Authors:  J C Benson; J A Trejo-Lopez; A M Nassiri; K Eschbacher; M J Link; C L Driscoll; R D Tiegs; J Sfeir; D R DeLone
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-19       Impact factor: 4.966

3.  FGF23 Producing Mesenchymal Tumor.

Authors:  Lucyna Papierska; Jarosław B Cwikła; Waldemar Misiorowski; Michał Rabijewski; Krzysztof Sikora; Hubert Wanyura
Journal:  Case Rep Endocrinol       Date:  2014-02-03

4.  Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss.

Authors:  Amir Ghorbani-Aghbolaghi; Morgan Angus Darrow; Tao Wang
Journal:  Autops Case Rep       Date:  2017-09-30

5.  Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.

Authors:  Jing Li; Yuanyuan Huang; Fuzhou Yang; Qi Zhang; Decai Chen; Qin Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.